Showing results (81-90 of 159) with videos related to
Sort By:
Pageof 16
Neuroscience Letters|April 13, 1992
The immediate consequences of middle cerebral artery occlusion on GABA synthesis in mouse cortex and cerebellumA R Green, A J Cross, M F Snape, et al.British Journal of Pharmacology|December 1, 1989
The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prismsT N Robinson, R J De Souza, A J Cross, et al.Journal of Receptor Research|January 1, 1987
Autoradiographic analysis of [3H]kainic acid binding in primate brainA J Cross, W J Skan, P Slater, et al.British Journal of Pharmacology|August 1, 1994
The differential effects of felodipine and nitrendipine on cerebral dihydropyridine binding ex vivo and the ethanol withdrawal syndrome in miceW P Watson, A Misra, A J Cross, et al.Psychopharmacology|January 1, 1982
Behavioural and biochemical effects of chronic amphetamine treatment in the vervet monkeyR M Ridley, H F Baker, F Owen, et al.Pharmacology & Toxicology|October 23, 1998
An investigation of the possible interaction of clomethiazole with glutamate and ion channel sites as an explanation of its neuroprotective activityA R Green, A Misra, K E Hewitt, et al.Neuropharmacology|January 1, 1996
A behavioural and neurochemical study in rats of the pharmacology of loreclezole, a novel allosteric modulator of the GABAA receptorA R Green, A Misra, T K Murray, et al.Psychopharmacology|January 1, 1981
Effect of chronic amphetamine administration on central dopaminergic mechanisms in the vervetF Owen, H F Baker, R M Ridley, et al.Neuroscience Letters|November 23, 1984
Striatal dopamine receptors in Alzheimer-type dementiaA J Cross, T J Crow, I N Ferrier, et al.Journal of the Neurological Sciences|December 1, 1985
Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntington's disease and Alzheimer-type dementiaA J Cross, T J Crow, J A Johnson, et al.Pageof 16